Chery Auto posts an 8.4% growth in March amid COVID-19

Chery Auto in March of 2020 was able to export 8,860 units including the Tiggo 8, Tiggo 7, and  Tiggo 5x crossover. With the units sold the automotive company was able to grow by 11.2% compared to the same period last year. From January all the way to March of 2020 the automaker was able to export 26,503 units in total.

Chery currently has 12 facilities and factories producing either complete vehicles or complete knock-down kits, a collection of vehicle parts that can be put together in other assembly plants to form a complete unit. These facilities also include sales and service networks spread across 1,500 dealers worldwide. The automotive brand assures its dealer partners and customers that despite the onset of the COVID-19 pandemic, it is doing its best to meet the demand of the growing market. The brand also assures them that it has already secured its export and overseas operations.

Since February of 2020, the automaker was slowly able to ramp up its overseas production of vehicles as it was one of the earliest companies that were able to resume production. Chery was also active during the onset of the pandemic as the brand was able to give out 700,000 pieces of medical supplies which included N95 masks, disposable medical masks, medical gloves, and protective clothing as well. These were given out to its overseas partners located in over 20 countries and to facilities in its home country of China as well.

Aside from the medical equipment donations, Chery also lent a helping hand through its contact network in China. The automotive brand paired up local hospitals with better-equipped facilities in order to help them provide a better remote diagnosis. Through the pairing, the automotive brand together with its overseas partners was able to help the local population fight against the still ongoing Coronavirus pandemic. With Chery being recently relaunched into the country it is proving that despite it being a newcomer it can still help out in the fight against the COVID-19 pandemic.